Japan Neurology Clinical Trials Market

The Japan neurology clinical trials market comprises the research and development of new drugs, therapies, and medical devices for treating nervous system conditions like Alzheimer's and Parkinson's. The primary customers are pharmaceutical companies and research institutions that leverage Japan's world-class universities and hospitals. Key growth drivers include the country's rapidly aging population, which increases the prevalence of age-related neurological diseases, and its advanced, efficient infrastructure for conducting clinical research.